CERTIOR FINANCIAL GROUP, LLC

Position in NVS — Novartis AG

CIK 2055620 KING OF PRUSSIA, PA

Position in NVS

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$510,490

+$52,624 QoQ

Shares Held

3,342

+0.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.70%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CERTIOR FINANCIAL GROUP, LLC holds $2,346,554 across 5 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,346	$590,347
2	GILD	Gilead Sciences, Inc.	4,007	$506,244
3	AZN	Astrazeneca PLC	2,359	$447,313
4	MRK	Merck & Co., Inc.	3,339	$429,061
5	JNJ	Johnson & Johnson	1,471	$373,589

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$510,490	3,342	+0.6%	Shares	Sole	2026-04-27
2025-12-31	$457,866	3,321	+7.5%	Shares	Sole	2026-02-04
2025-09-30	$396,133	3,089	-6.1%	Shares	Sole	2025-10-31
2025-06-30	$398,122	3,290	-1.6%	Shares	Sole	2025-08-13
2025-03-31	$372,900	3,345	+1.8%	Shares	Sole	2025-05-15
2024-12-31	$319,663	3,285	—	Shares	Sole	2025-02-13
No filing history on record for this holder in this stock.